Dr Lorey K Smith
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
26 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma
DOI: 10.1136/jitc-2025-0115512025
Journal article
Ubiquitous expression of an activating mutation in the Pik3ca gene reprograms glucose and lipid metabolism in mice
DOI: 10.1371/journal.pone.03225442025
Journal article
BRAF/MEK inhibition following immune checkpoint inhibitors promotes antitumor immunity associated with expansion of progenitor-exhausted CD8⁺ T cells
DOI: 10.1016/j.ejcskn.2025.1007372023
Journal article
The therapeutic potential of targeting minimal residual disease in melanoma
DOI: 10.1002/ctm2.11972022
Journal article
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma
DOI: 10.1038/s41467-022-28705-x2022
Journal article
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
DOI: 10.1016/j.celrep.2022.1115712022
Journal article
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
DOI: 10.15252/emmm.202115203
RECENT SCHOLARLY WORKS
2022
Journal article
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
DOI: 10.1158/2159-8290.CD-21-05222021
Journal article
Enhancing adoptive cell transfer with combination braf-mek and cdk4/6 inhibitors in melanoma
DOI: 10.3390/cancers132463422021
Journal article
Phenotypic consequences of slc25a40-abcb1 fusions beyond drug resistance in high-grade serous ovarian cancer
DOI: 10.3390/cancers13225644